Two New Cancer Researchers Join College of Pharmacy Faculty

05/09/2016

The Ohio State University College of Pharmacy is pleased to announce that Lara Sucheston-Campbell, PhD, and Moray Campbell, PhD, have joined the College of Pharmacy faculty. Both come from the Department of Cancer Prevention and Population Sciences at Roswell Park Cancer Institute in Buffalo NY.

Lara Sucheston-Campbell

“We are excited to have Drs. Sucheston-Campbell and Campbell join the college,” said Henry J. Mann, PharmD, FCCP, FCCM, FASHP, Dean and Professor at Ohio State’s College of Pharmacy. “Their addition continues to add depth and breadth to our faculty.”

Lara Sucheston-Campbell is an associate professor with tenure in the Division of Pharmacy Practice & Science. She is a genetic epidemiologist, recruited through Ohio State’s Translational Data Analytics Discovery Theme initiative. Her appointment is shared between the College of Pharmacy and the College of Veterinary Medicine Department in Veterinary Biosciences. “We are excited about enhancing multi-disciplinary translational research through this collaboration,” said Mann.

Moray Campbell

Dr. Sucheston-Campbell, is a genetic epidemiologist who came to Ohio State from Roswell Park Cancer Institute (RPCI), where she served as an Assistant Member (2007-2014) and Associate member (2014-) as well as member of the graduate faculty at the University of Buffalo, State University of New York during this time.

Dr. Sucheston-Campbell earned a BA in English and a BS in Economics at Arizona State University; an MS in Operations Research in the Department of Industrial Engineering at State University of New York at Buffalo; and a PhD in Genetic and Molecular Epidemiology from Case Western Reserve University’s School of Medicine. She was awarded with the Jane M. Olson Memorial Award for Dissertation Research in 2007. She is currently an NIH funded investigator and a PI on a multi-institutional multi-PI study focused on Determining the Outcomes of Susceptibility Conveying Variants Related to 1-year survival following Blood or Marrow Transplant (DISCOVeRY-BMT).

Moray Campbell is a research associate professor in the Division of Pharmaceutics. His research is focused on nuclear receptor signaling and epigenetic gene regulation in prostate cancer.    

Campbell served as associate professor of Oncology and associate member of the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute, a position he held beginning in 2007. From 2011—2015, he served as associate dean of the Roswell Park Graduate Division at the University at Buffalo, State University of New York; in 2015, he became a distinguished member of the graduate faculty.

Campbell earned a BSc in Applied and Industrial Biology from South Bank Polytechnic in London; a PhD in Microbiology from the University of Kent, Kent UK; and an MS in Bioinformatics from the Krieger School of Arts and Sciences at Johns Hopkins University. He is recipient of numerous awards, including the Gilliard Exchange Fellowship award from the British Association for Cancer Research in 2000 and the Clinical Sciences Translational Research Fellow award from Roswell Park Cancer Institute /University of Buffalo at State College of New York.